R, H., AM, W., & JN, C. (2019). Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: Evidence to date. Dove Medical Press.
Chicago Style (17th ed.) CitationR, Howell, Wright AM, and Clements JN. Clinical Potential of Liraglutide in Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: Evidence to Date. Dove Medical Press, 2019.
MLA (8th ed.) CitationR, Howell, et al. Clinical Potential of Liraglutide in Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: Evidence to Date. Dove Medical Press, 2019.
Warning: These citations may not always be 100% accurate.